Skip to main content

This Bearish Biotech ETF Is up 16% in the Past Month

The biotech sector was one of the darlings amid the vaccine rally in 2020, but there’s since been some bearishness, which is benefiting the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed 16% the past month, giving bearish biotech traders something to cheer about. Of...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.